Objective To observe the changes of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with coronary heart disease.

• 摘要目的观察冠心病患者血浆组织因子(TF)、组织因子途径抑制物(TFPI)水平的变化及其临床意义。